MARKET

OGEN

OGEN

ORAGENICS
AMEX

Real-time Quotes | Nasdaq Last Sale

0.6248
+0.0564
+9.92%
After Hours: 0.6200 -0.0048 -0.77% 17:58 04/08 EDT
OPEN
0.5800
PREV CLOSE
0.5684
HIGH
0.6300
LOW
0.5550
VOLUME
861.69K
TURNOVER
--
52 WEEK HIGH
0.8790
52 WEEK LOW
0.3500
MARKET CAP
28.82M
P/E (TTM)
-1.6697
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average OGEN stock price target is 2.250 with a high estimate of 2.500 and a low estimate of 2.000.

EPS

OGEN News

More
  • The Week Ahead In Biotech: Spotlight On Q1 Pre-Announcements As COVID-19 Continues To Disrupt Operations
  • Benzinga · 3d ago
  • OGEN: Results from Phase 2 Trial of AG013 in Early 2Q20
  • Zacks Small Cap Research · 03/09 15:50
  • Oragenics files for $50M equity offering
  • seekingalpha · 01/01 02:15
  • We're Keeping An Eye On Oragenics's (NYSEMKT:OGEN) Cash Burn Rate
  • Simply Wall St. · 12/10/2019 16:16

Industry

Biotechnology & Medical Research
+3.08%
Pharmaceuticals & Medical Research
+2.83%

Hot Stocks

Symbol
Price
%Change

About OGEN

Oragenics, Inc. develops, markets and sells probiotics specifically designed to enhance oral health for humans and pets, under the brand names Evora and ProBiora. The Company is focused on offering antibiotics against infectious disease and on developing treatments for oral mucositis. It is engaged in developing its antibiotic product candidate, MU1140, as well as other homolog antibiotic product candidates; researching AG013 in connection with the treatment of Oral Mucositis; commercializing its ProBiora3 probiotic products, and has other product candidates for out licensing or partnering. MU1140 is an antibiotic that is produced by the parent of the SMaRT strain. ProBiora3 is a blend of three naturally occurring strains of beneficial bacteria, including Streptococcus oralis KJ3, Streptococcus uberis KJ2 and Streptococcus rattus JH145. LPT3-04 is a compound, which is consumed in the human diet in small amounts and results in dose-dependent weight loss in experimental animal models.
More

Webull offers kinds of Oragenics Inc stock information, including AMEX:OGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OGEN stock news, and many more online research tools to help you make informed decisions.